Antibiotic resistance among anaerobic Gram-negative bacilli:: lessons from a French multicentric survey

被引:42
作者
Behra-Miellet, J
Calvet, L
Mory, F
Muller, C
Chomarat, M
Bézian, MC
Bland, S
Juvenin, ME
Fosse, T
Goldstein, F
Jaulhac, B
Dubreuil, L
机构
[1] Fac Sci Pharmaceut & Biol, Bacteriol Lab, F-59006 Lille, France
[2] Univ Hosp Nancy, Nancy, France
[3] Univ Hosp Bichat, Paris, France
[4] Univ Hosp Lyon Sud, Lyon, France
[5] Univ Hosp Bordeaux, Bordeaux, France
[6] Hosp Annecy, Annecy, France
[7] Univ Hosp Nantes, Nantes, France
[8] Univ Hosp Nice, Nice, France
[9] Univ Hosp St Joseph, Paris, France
[10] Univ Hosp Strasbourg, Strasbourg, France
关键词
anaerobic bacteria; antibiotic resistance; antibiotic survey; Bacteroides fragilis;
D O I
10.1016/S1075-9964(03)00066-0
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Temporal changes of antibiotic susceptibilities among anaerobes in France are followed in our laboratory since 1992. For Bacteroides strains, resistance increased from 1992 to 1998 for amoxicillin-clavulanic acid, cefotetan and clindamycin. The present study evaluates the situation in 2000 for 434 Gram-negative anaerobic clinical isolates (obtained from 9 large university hospitals) by testing amoxicillin and ticarcillin alone or combined with clavulanic acid, cefoxitin, cefotetan, imipenem, clindamycin and metronidazole (using the NCCLS-approved method for MIC determination. The main genera tested included Bacteroides (359 strains of the fragilis group), Prevotella (40 strains), Fusobacterium (23 strains) and miscellaneous species (8 strains). Resistance rates within the B. fragilis group were: amoxicillin-clavulanic acid 5.6%, ticarcillin 33%, ticarcillin-clavulanic acid 2%, cefoxitin 13%, cefotetan 44%, clindamycin 33%, imipenem 1% and metronidazole < 1%, respectively. Only one strain of B. fragilis was resistant to metronidazole (MIC = 64 mg/L); due to the presence of the nimA gene on the chromosome. Resistance to imipenem or metronidazole was only found among the B. fragilis species. These two former drugs excepted, B. fragilis was less resistant to antibiotics than the other species. beta-lactamase production was detected for 357/359 strains of the fragilis group, 26/40 stains of Prevotella and 3/23 strains of Fusobacterium. Dynamic changes of antibacterial resistance are occurring within the B. fragilis group: decreased resistance to amoxicillinclavulanic acid. ticarcillin-clavulanic acid, imipenem while resistance for cefoxitin, cefotetan, clindamycin continues to increase. Regular antibiotic surveys are needed as a source of information to guide the empirical therapy of anaerobic infections. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:105 / 111
页数:7
相关论文
共 17 条
[1]   In vitro susceptibilities of the Bacteroides fragilis group species:: Change in isolation rates significantly affects overall susceptibility data [J].
Aldridge, KE ;
O'Brien, M .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (11) :4349-4352
[2]   Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species [J].
Aldridge, KE ;
Ashcraft, D ;
Cambre, K ;
Pierson, CL ;
Jenkins, SG ;
Rosenblatt, JE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (04) :1238-1243
[3]  
BLAND S, 1995, PATHOL BIOL, V43, P289
[4]   ISOLATION OF BACTEROIDES STRAINS WITH REDUCED SENSITIVITY TO 5-NITROIMIDAZOLES [J].
DUBLANCHET, A ;
CAILLON, J ;
EMOND, JP ;
CHARDON, H ;
DRUGEON, HB .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1986, 5 (03) :346-347
[5]   SURVEY OF THE SUSCEPTIBILITY PATTERNS OF BACTEROIDES-FRAGILIS GROUP STRAINS IN FRANCE FROM 1977 TO 1992 [J].
DUBREUIL, L ;
BREUIL, J ;
DUBLANCHET, A ;
SEDALLIAN, A .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1992, 11 (11) :1094-1099
[6]  
DUBREUIL L, 1997, 37 INT C ANT AG CHEM
[7]  
DUBREUIL L, 1999, ANTIBIOTIQUES, V1, P147
[8]  
DUBREUIL L, 2000, SPANISH J CHEMOTH S2, V13, P100
[9]   New findings in beta-lactam and metronidazole resistant Bacteroides fragilis group [J].
Fang, H ;
Edlund, C ;
Hedberg, M ;
Nord, CE .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2002, 19 (05) :361-370
[10]  
GROLLIER G, 1994, PATHOL BIOL, V42, P498